Wormwood in Chronic Progressive Disorders With Reduced Appetite
NCT ID: NCT01126931
Last Updated: 2010-05-20
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
300 participants
OBSERVATIONAL
2006-02-28
2012-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Trial aims at observing beneficial effects of wormwood supplementation in various chronic disorders associated with reduced appetite
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
DaHuang GangTsao Tang to Improve the Appetite Loss Condition of Cancer Patients
NCT01503346
Homeopathic Drug Proving Trial
NCT01061229
Ashwagandha for Cognitive Dysfunction
NCT04092647
Real-world Momentary Assessment of Kratom Use Accompanied by Product Assays: A Natural-history Study for Interdisciplinary Characterization of Kratom Use and Pharmacology
NCT05457803
Efficacy of Nepeta Menthoides Extract on Anxiety of Patients With Depression: a Double-blind Randomized Controlled Clinical Trial
NCT02565316
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Examples:
1. Cancer
2. Autoimmune diseases such as Crohns disease and IgA Nephropathy
3. Old age
4. Chronic stress and depression
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Chronic progressive disease
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital Freiburg
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Medical Faculty, University of Saarland, Homburg, Germany
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Simone S Krebs, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Freiburg, Nuclear Medicine, Germany
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Freiburg, Medical Faculty
Freiburg im Breisgau, Baden, Germany
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Omer B, Krebs S, Omer H, Noor TO. Steroid-sparing effect of wormwood (Artemisia absinthium) in Crohn's disease: a double-blind placebo-controlled study. Phytomedicine. 2007 Feb;14(2-3):87-95. doi: 10.1016/j.phymed.2007.01.001. Epub 2007 Jan 19.
Krebs S, Omer TN, Omer B. Wormwood (Artemisia absinthium) suppresses tumour necrosis factor alpha and accelerates healing in patients with Crohn's disease - A controlled clinical trial. Phytomedicine. 2010 Apr;17(5):305-9. doi: 10.1016/j.phymed.2009.10.013. Epub 2009 Dec 3.
Krebs S, Omer B, Omer TN, Fliser D. Wormwood (Artemisia absinthium) for poorly responsive early-stage IgA nephropathy: a pilot uncontrolled trial. Am J Kidney Dis. 2010 Dec;56(6):1095-9. doi: 10.1053/j.ajkd.2010.06.025. Epub 2010 Sep 16.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
Appetite and Weight Loss
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.